DMSO (dimethyl sulfoxide) is not an approved or proven treatment for cancer. Its only FDA-approved use in humans is a 50% solution administered into the bladder for a condition called interstitial cystitis, approved in 1978. No version of DMSO has been approved, at any dose or by any route, for treating any type of cancer. That said, DMSO does play real roles in cancer care as a supporting tool, and laboratory research has explored its effects on cancer cells. Here’s what the science actually shows.
What Lab Studies Have Found
DMSO has genuine biological effects on cancer cells in laboratory dishes. In studies on human leukemia cells (a line called HL-60), DMSO pushed immature, rapidly dividing cancer cells to mature into something closer to normal white blood cells. This process, called differentiation, is significant because mature cells stop multiplying uncontrollably. Exposure to DMSO for as little as 8 to 18 hours was enough to commit these leukemia cells to maturing, and their ability to keep proliferating dropped sharply afterward.
Beyond differentiation, researchers have observed DMSO activating a tumor-suppressing protein called PTEN and triggering programmed cell death in cancer cells. It appears to alter how genes are expressed by changing the physical shape of DNA and the proteins that interact with it. A 2022 review in Cancer Diagnosis & Prognosis described these as rational grounds for further research into DMSO as a differentiation-inducing agent.
The critical caveat: these findings come from cells in a petri dish, not from people. Many substances kill cancer cells in a lab but fail completely in the human body because they can’t reach tumors at effective concentrations, cause unacceptable side effects, or simply don’t work the same way in living tissue. No clinical trial has demonstrated that DMSO shrinks tumors or improves survival in cancer patients.
How DMSO Is Actually Used in Cancer Care
While DMSO isn’t a cancer treatment itself, it plays two practical roles in oncology that are well supported by evidence.
Stem Cell Transplant Preservation
When patients with leukemia, lymphoma, or multiple myeloma undergo stem cell transplants, their harvested stem cells need to be frozen and stored. DMSO is the standard cryoprotectant, the chemical that prevents ice crystals from destroying cells during freezing. It’s mixed into the preservation solution at concentrations typically between 5% and 10%. A randomized trial of 150 patients found that lowering the DMSO concentration from 10% to 5% or 7.5% had no negative impact on how well the transplanted cells took hold afterward, while producing fewer side effects during infusion.
Chemotherapy Extravasation Rescue
When chemotherapy drugs leak out of a vein into surrounding tissue (called extravasation), the damage can be severe, sometimes causing deep ulcers. Topical DMSO at 99% concentration, applied to the skin over the leak site every 8 hours for 7 days, has proven effective at preventing this tissue destruction. In a prospective study of 127 patients who experienced extravasation from drugs like doxorubicin, epirubicin, cisplatin, and others, only one patient developed an ulcer. The treatment was well tolerated, with mild local burning and a garlic-like breath odor as the main side effects.
DMSO as a Drug Delivery Vehicle
One of DMSO’s most distinctive properties is its ability to penetrate skin rapidly and carry other molecules with it. It can transport both water-soluble and fat-soluble compounds through the skin barrier, which is why it’s widely used in topical pharmaceutical formulations. Some alternative health websites suggest using this property to “deliver” anti-cancer compounds through the skin directly to tumors. This idea misunderstands how drug delivery works. DMSO enhances absorption through the skin into the bloodstream, but it doesn’t selectively target tumors. There is no evidence that rubbing DMSO mixed with any substance onto your skin treats cancer beneath it.
Side Effects and Safety Concerns
DMSO is not harmless, particularly when given intravenously (as happens during stem cell transplant infusions). A systematic review of adverse reactions found that about 17% of patients receiving IV DMSO experienced nausea, 11% had vomiting, and smaller percentages developed diarrhea or bad breath. More concerning, almost all reported cardiovascular side effects, including drops in blood pressure, abnormal heart rhythms, and in rare cases cardiac arrest, occurred with intravenous use. Both gastrointestinal and cardiovascular reactions were dose-dependent: higher amounts of DMSO meant more frequent and more serious side effects.
Topical use carries its own risks. DMSO pulls virtually anything on your skin’s surface into your body. If you apply industrial-grade DMSO, which may contain heavy metals, residual solvents, or other manufacturing byproducts, those contaminants go straight into your bloodstream. Only pharmaceutical-grade DMSO has been purified to a standard appropriate for human use, and even then, you need to apply it to thoroughly clean skin.
The garlic-like taste and body odor that DMSO causes is nearly universal. It happens because your body metabolizes DMSO into a sulfur compound that you exhale and secrete through your pores. It’s not dangerous, but it’s persistent and unmistakable.
Why the FDA Has Issued Warnings
The FDA has actively pursued companies marketing DMSO as a cancer treatment. In 2021, the agency issued a warning letter to a website selling “DMSO Liquid 70/30” alongside claims that it could treat tumors, cancer, and other serious diseases. The FDA classified these products as unapproved new drugs, noting they are “not generally recognized as safe and effective for the uses recommended or suggested in their labeling.” The agency required the company to remove all disease-treatment claims or submit a formal new drug application backed by clinical trial data, which would cost hundreds of millions of dollars and take years to complete.
This enforcement action reflects a broader pattern. DMSO has been promoted as an underground cancer cure since the 1960s, largely based on its dramatic ability to penetrate tissue and its real but limited laboratory effects on cancer cells. The gap between those lab findings and a working cancer treatment in humans has never been bridged by clinical evidence. No oncology guideline from any major medical organization includes DMSO as a cancer therapy.
What This Means Practically
If you’re considering DMSO because you or someone you care about has cancer, the honest picture is this: DMSO has interesting biological properties that scientists continue to study, it plays a genuine supporting role in certain cancer procedures like stem cell transplants and extravasation management, and it has real potential as a drug delivery tool. But there is no clinical evidence that applying DMSO to your skin, drinking it, or receiving it intravenously treats cancer in humans. The lab research on leukemia cell differentiation, while scientifically legitimate, has not translated into a treatment protocol that works in living patients.
Products sold online as DMSO cancer treatments are unregulated, potentially contaminated, and backed by claims the FDA considers illegal. The compound’s remarkable ability to absorb through skin makes purity especially critical, since impurities in industrial-grade products bypass your body’s normal defenses entirely.